IDERA PHARMACEUTICALS INC's ticker is IDRA and the CUSIP is 45168K405. A total of 33 filers reported holding IDERA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $386 | – | 1,102 | +10.2% | 0.00% | – |
| Q3 2022 | $0 | – | 1,000 | -9.1% | 0.00% | – |
| Q2 2022 | $0 | – | 1,100 | +10.0% | 0.00% | – |
| Q1 2022 | $0 | -100.0% | 1,000 | -20.0% | 0.00% | – |
| Q4 2021 | $1,000 | -98.8% | 1,250 | -98.5% | 0.00% | – |
| Q3 2021 | $84,000 | +8300.0% | 82,014 | +6874.0% | 0.00% | – |
| Q2 2021 | $1,000 | -66.7% | 1,176 | -48.0% | 0.00% | – |
| Q1 2021 | $3,000 | -98.4% | 2,260 | -95.5% | 0.00% | – |
| Q4 2020 | $184,000 | -72.4% | 50,220 | -83.9% | 0.00% | – |
| Q3 2020 | $667,000 | +666.7% | 311,527 | +372.3% | 0.00% | – |
| Q1 2020 | $87,000 | +4250.0% | 65,953 | +6495.3% | 0.00% | – |
| Q4 2019 | $2,000 | -60.0% | 1,000 | -38.6% | 0.00% | – |
| Q3 2019 | $5,000 | -89.4% | 1,629 | -90.7% | 0.00% | – |
| Q2 2019 | $47,000 | +193.8% | 17,498 | +177.1% | 0.00% | – |
| Q1 2019 | $16,000 | -33.3% | 6,314 | -27.5% | 0.00% | – |
| Q4 2018 | $24,000 | -46.7% | 8,708 | +72.7% | 0.00% | – |
| Q3 2018 | $45,000 | – | 5,043 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ABG Innovation Capital Partners III GP Ltd | 56,250 | $68,000 | 0.23% |
| Virtu Financial LLC | 325,330 | $390,000 | 0.04% |
| HOLLENCREST CAPITAL MANAGEMENT | 141,000 | $169,000 | 0.02% |
| Clear Creek Financial Management, LLC | 49,696 | $60,000 | 0.01% |
| Palo Alto Investors LP | 77,044 | $92,000 | 0.01% |
| ACADIAN ASSET MANAGEMENT LLC | 738,620 | $886,000 | 0.00% |
| MARSHALL WACE, LLP | 477,449 | $573,000 | 0.00% |
| WADE G W & INC | 35,000 | $42,000 | 0.00% |
| TWO SIGMA ADVISERS, LP | 599,471 | $719,000 | 0.00% |
| BRYN MAWR TRUST Co | 33,892 | $41,000 | 0.00% |